Journal
NEUROLOGY
Volume 94, Issue 1, Pages E30-E41Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000008696
Keywords
-
Categories
Funding
- INSERM
- IHU-A-ICM
- Pfizer
- Investissement d'Avenir (Agence Nationale de la Recherche-10-IA Agence Institut) [Hospitalo-Universitaire-6 [ANR-10-AIHU-06]]
- Foundation Plan-Alzheimer
- AVID/Lilly
- Program PHOENIX led by the Sorbonne University Foundation
- la Fondation pour la Recherche sur Alzheimer
- AXA Research Fund
- Fondation partenariale Sorbonne Universit'oundation
- Fondation pour la Recherche sur Alzheimer, Paris, France
- Swedish Research Council [2017-00915]
- European Research Council
- Swedish State Support for Clinical Research (ALFGBG)
- UK Dementia Research Institute at UCL
- Swedish Alzheimer Foundation [AF-742881]
- Hjarnfonden, Sweden [FO20170243, ALFGBG-715986]
- County Councils
- ALF-agreement
Ask authors/readers for more resources
Objective To investigate whether baseline concentrations of plasma total tau (t-tau) and neurofilament light (NfL) chain proteins are associated with annual percent change (APC) of the basal forebrain cholinergic system (BFCS) in cognitively intact older adults at risk for Alzheimer disease (AD). Methods This was a large-scale study of 276 cognitively intact older adults from the monocentric INSIGHT-preAD (Investigation of Alzheimer's Predictors in Subjective Memory Complainers) cohort. Participants underwent baseline assessment of plasma t-tau and NfL concentrations as well as baseline and 24-month follow-up MRI scans. Linear models with and without influential observations (calculated using the Cook distance) were carried out to investigate the effect of plasma NfL and t-tau concentrations, and their interaction effect with beta-amyloid status and APOE genotype, on the APC of the whole BFCS and its anterior (Ch1/2) and posterior (Ch4) subdivisions separately. Results Higher plasma t-tau concentrations at baseline were associated with higher BFCS rate of atrophy (model without influencers: n = 251, F value = 4.6815; p value = 0.031). Subregional analyses showed similar results for both the APC of the Ch1/2 (model without influencers: n = 256, F value = 3.9535, p corrected = 0.047) and Ch4 BFCS sectors (model without influencers: n = 253, F value = 4.9090, p corrected = 0.047). Baseline NfL, beta-amyloid load, and APOE << 4 carrier status did not affect APC of the BFCS. Conclusion Increased concentrations of baseline plasma t-tau may predict in vivo structural BFCS atrophy progression in older adults at risk for AD, independently of beta-amyloid status and APOE genotype.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available